bromodeoxyuridine has been researched along with alitretinoin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischoff, ED; Davies, PJ; Gregory, ML; Hayes, JS; Heyman, RA; Lamph, WW; Shalinsky, DR; Thomazy, V | 1 |
| Hong, SH; Kadosawa, T; Matsunaga, S; Mochizuki, M; Nishimura, R; Nozaki, K; Sasaki, N | 1 |
| Dagli, ML; Jordão Júnior, AA; Moreno, FS; Naves, MM; Silveira, ER; Vannucchi, H | 1 |
| Blauberger, S; Ganslmayer, M; Hahn, EG; Herold, C; Ocker, M; Schuppan, D; Zopf, S | 1 |
4 other study(ies) available for bromodeoxyuridine and alitretinoin
| Article | Year |
|---|---|
Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice.
Topics: Alitretinoin; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Mice; Mice, Nude; Mouth Neoplasms; Neoplasm Transplantation; Receptors, Retinoic Acid; Retinoid X Receptors; Transcription Factors; Transplantation, Heterologous; Tretinoin | 1996 |
In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells.
Topics: Alitretinoin; Animals; Antimetabolites; Antineoplastic Agents; Bone Neoplasms; Bromodeoxyuridine; Cell Division; DNA; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Microscopy, Phase-Contrast; Osteosarcoma; Tretinoin; Tumor Cells, Cultured | 2000 |
Vitamin A and all-trans and 9-cis retinoic acids inhibit cell proliferation during the progression phase of hepatocarcinogenesis in Wistar rats.
Topics: 2-Acetylaminofluorene; Alitretinoin; Animals; Anticarcinogenic Agents; Bromodeoxyuridine; Carcinogens; Cell Division; Diethylnitrosamine; DNA; Glutathione Transferase; Immunohistochemistry; Liver; Liver Neoplasms; Male; Rats; Rats, Wistar; Tretinoin; Vitamin A | 2001 |
Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells.
Topics: Alitretinoin; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Bromodeoxyuridine; Carcinoma; Caspase 3; Caspases; Cell Division; Cell Line, Tumor; Cell Separation; Ciprofloxacin; Colonic Neoplasms; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunohistochemistry; Indicators and Reagents; Kinetics; Prognosis; Propidium; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tamoxifen; Time Factors; Tretinoin | 2003 |